泽璟制药-U涨5% 纳入科创生物医药指数

智选洞察2025-05-13

05月13日，泽璟制药-U（688266）股价大幅上涨，截至09点35分，泽璟制药-U上涨5.00%，报96.32元/股，成交8927万元，换手率0.35%。消息解读西安电子科技大学邓宏章教授团队以创新性非离子递送系统，成功破解“毒性-效率”死锁，为基因治疗装上“安全导航”。中证指数有限公司将于2025年5月13日正式发布中证科创创业生物医药指数和中证科创创业新能源指数，为市场提供更丰富的投资标的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535757999?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-13 09:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535757999","market":"sh","top_or_hot":-1,"title":"泽璟制药-U涨5% 纳入科创生物医药指数","media":"智选洞察","content":"<div>\n<p>05月13日，泽璟制药-U（688266）股价大幅上涨，截至09点35分，泽璟制药-U上涨5.00%，报96.32元/股，成交8927万元，换手率0.35%。消息解读西安电子科技大学邓宏章教授团队以创新性非离子递送系统，成功破解“毒性-效率”死锁，为基因治疗装上“安全导航”。中证指数有限公司将于2025年5月13日正式发布中证科创创业生物医药指数和中证科创创业新能源指数，为市场提供更丰富的投资标的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513093814a47c0964&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泽璟制药-U涨5% 纳入科创生物医药指数</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泽璟制药-U涨5% 纳入科创生物医药指数\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-13 09:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513093814a47c0964&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>05月13日，泽璟制药-U（688266）股价大幅上涨，截至09点35分，泽璟制药-U上涨5.00%，报96.32元/股，成交8927万元，换手率0.35%。消息解读西安电子科技大学邓宏章教授团队以创新性非离子递送系统，成功破解“毒性-效率”死锁，为基因治疗装上“安全导航”。中证指数有限公司将于2025年5月13日正式发布中证科创创业生物医药指数和中证科创创业新能源指数，为市场提供更丰富的投资标的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513093814a47c0964&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159938","symbol_name":"医药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513093814a47c0964&s=b","article_id":"2535757999","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513093814a47c0964&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535757999","pubTimestamp":1747100142,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"05月13日，泽璟制药-U股价大幅上涨，截至09点35分，泽璟制药-U上涨5.00%，报96.32元/股，成交8927万元，换手率0.35%。中证指数有限公司将于2025年5月13日正式发布中证科创创业生物医药指数和中证科创创业新能源指数，为市场提供更丰富的投资标的。资金动向截止发稿，泽璟制药-U获得主力净流出218万元，其中超大单流入42万元，大单流出260万元。主营业务及业绩泽璟制药-U公司主营业务为化学新药及生物新药的研发、生产及销售。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","688266":"泽璟制药-U","000683.SH":"科创生物","BK0239":"医药制造"},"translate_title":"Zejing Pharmaceutical-U rose 5% and was included in the Science and Technology Innovation Biomedicine Index","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"688266":1,"000683.SH":1},"content_text":"05月13日，泽璟制药-U（688266）股价大幅上涨，截至09点35分，泽璟制药-U上涨5.00%，报96.32元/股，成交8927万元，换手率0.35%。消息解读西安电子科技大学邓宏章教授团队以创新性非离子递送系统，成功破解“毒性-效率”死锁，为基因治疗装上“安全导航”。中证指数有限公司将于2025年5月13日正式发布中证科创创业生物医药指数和中证科创创业新能源指数，为市场提供更丰富的投资标的。中证科创创业生物医药指数从科创板和创业板中选取50只提供细胞医疗、基因测序、血液制品、生物技术药物、疫苗、体外诊断等产品和服务的上市公司证券作为指数样本，反映上述板块中生物医药主题上市公司证券的整体表现。此外，数据统计显示，近半年内1家券商给予增持建议，10家券商给予买入建议。资金动向截止发稿，泽璟制药-U获得主力净流出218万元，其中超大单流入42万元，大单流出260万元。数据显示，该股今日净流入较近5日净流入均值增加2590万元。主营业务及业绩泽璟制药-U公司主营业务为化学新药及生物新药的研发、生产及销售。最新财报显示，今年一季报，泽璟制药-U实现营业收入1.68亿元，同比增长54.87%，净利润为-2,826.22万元，同比增长28.45%，基本每股收益为-0.11元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535757999","isCrawlerRequest":true}